These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2021114)

  • 21. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurogenic mechanisms initiating essential hypertension.
    Egan BM
    Am J Hypertens; 1989 Dec; 2(12 Pt 2):357S-362S. PubMed ID: 2688692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H; Julius S
    Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autonomic nervous system in arterial hypertension].
    Grassi G
    Ital Heart J Suppl; 2001 Aug; 2(8):850-6. PubMed ID: 11582717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the sympathetic nervous system in the pathophysiology of cardiovascular disease.
    Julius S
    Am Heart J; 1987 Jul; 114(1 Pt 2):232-4. PubMed ID: 3604881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the autonomic nervous system in mild human hypertension.
    Julius S; Esler MD; Randall OS
    Clin Sci Mol Med Suppl; 1975 Jun; 2():243s-252s. PubMed ID: 802640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G; Mancia G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance in essential hypertension: a psychophysiological approach to the "chicken and egg" question.
    Nazzaro P; Triggiani R; Ciancio L; Scarano AM; Pirrelli AM
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):275-86. PubMed ID: 11213537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.
    Tewari HK; Gadia R; Kumar D; Venkatesh P; Garg SP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3474-8. PubMed ID: 16877418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension.
    Julius S
    Clin Exp Hypertens; 1996; 18(3-4):305-21. PubMed ID: 8743023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomic nervous cardiovascular regulation in borderline hypertension.
    Julius S; Esler M
    Am J Cardiol; 1975 Oct; 36(5):685-96. PubMed ID: 171939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.
    Modan M; Halkin H
    Diabetes Care; 1991 Jun; 14(6):470-87. PubMed ID: 1864220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension?
    Julius S
    Clin Exp Hypertens; 1995; 17(1-2):375-86. PubMed ID: 7735282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of renin status to neurogenic vascular resistance in borderline hypertension.
    Esler MD; Julius S; Randall OS; Ellis CN; Kashima T
    Am J Cardiol; 1975 Oct; 36(5):708-15. PubMed ID: 1190091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer thinking on the hemodynamics of hypertension.
    Lund-Johansen P
    Curr Opin Cardiol; 1994 Sep; 9(5):505-11. PubMed ID: 7987028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic drive and vascular damage in hypertension and atherosclerosis.
    Pauletto P; Scannapieco G; Pessina AC
    Hypertension; 1991 Apr; 17(4 Suppl):III75-81. PubMed ID: 2013498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The "Neurocentric" Approach to Essential Hypertension: How Reliable is the Paradigm of Hyperkinetic Hypertension? A Focus on the Sympathetic Nervous System Dysregulation in Essential Hypertensive Patients with Elevated Resting Heart Rate.
    Di Raimondo D; Musiari G; Grova M; Miceli G; Tuttolomondo A; Pinto A
    Curr Pharm Des; 2017; 23(31):4635-4649. PubMed ID: 28891450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.